GlassScriptPhysician profile
Christopher R Balint
NPI 1609858703
$6,351.96
in general payments reported to CMS, 2019-2025
13 companies · $1,037 in 2025
The $1,037 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.59 · 2020: $51.98 · 2021: $1,504 · 2022: $2,776 · 2023: $287 · 2024: $681 · 2025: $1,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $2,692.21 | 2021-2022 | |
| Stryker Corporation | $1,993.74 | 2021-2025 | Inbone, Prophecy, Invision |
| Zimmer Biomet Holdings, INC. | $431.03 | 2024-2025 | Mymobility Platform, Persona, Comprehensive |
| Linvatec Corporation | $351.89 | 2024-2025 | Biobrace 23mm, Allograft Tissue, Linvatec Shoulder Arthroscopy |
| Smith+Nephew, INC. | $292.13 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Arthrex, INC. | $250.29 | 2022 | |
| Depuy Synthes Sales INC. | $138.29 | 2020-2023 | Bristow Latarjet |
| Mf Med | $122.77 | 2025 | |
| Heron Therapeutics, INC. | $25.61 | 2023 | Zynrelef |
| Pacira Therapeutics, INC. | $21.70 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $14.59 | 2019 | |
| Nevro Corp. | $11.68 | 2020 | |
| Orthofix Medical, INC. | $6.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Balint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.